BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $9
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
BTIG analyst Mark Massaro maintains Sophia Genetics (NASDAQ:SOPH) with a Buy and raises the price target from $8 to $9.
BTIG analyst Mark Massaro maintains Sophia Genetics (NASDAQ:SOPH) with a Buy and raises the price target from $8 to $9.